Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Hypothermia Systems Market
Therapeutic Hypothermia Systems Market size was valued at around USD 286.2 million in 2023 and is estimated to reach USD 433.2 million by 2032 with a CAGR of 4.8% over the forecast period. This robust market growth can be attributed to factors such as the increasing prevalence of cardiovascular and neurological disorders coupled with the growing awareness of the benefits of therapeutic hypothermia.
The rising prevalence of cardiovascular and neurological disorders has led to an expansion in the indications for therapeutic hypothermia. Clinical studies and medical guidelines increasingly recommend hypothermic therapy for conditions such as cardiac arrest, stroke, and traumatic brain injury, driving the demand for therapeutic hypothermia systems. For instance, according to the Sudden Cardiac Arrest Foundation, in 2022, there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S.
Therapeutic hypothermia systems refer to medical devices designed to induce and maintain a controlled reduction in body temperature for therapeutic purposes. This deliberate cooling of the body, typically within a precise temperature range, is employed as a therapeutic intervention in various medical conditions, particularly those involving neurological and cardiovascular disorders.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Therapeutic Hypothermia Systems Market Size in 2023: | USD 286.2 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 4.8% |
2032 Value Projection: | USD 433.2 Million |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 162 |
Tables, Charts & Figures: | 251 |
Segments covered: | Product Type, Indication, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|